1. Stocks
  2. Mankind Pharma Ltd.
  3. Swot
swot-logo

Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mankind Pharma Ltd. has 12 Strengths, 9 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Consistent Highest Return Stocks over Five Years - Nifty500

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Company with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Top Gainers

Volume Shockers

Promoter decreasing their shareholding

PE higher than Industry PE

Promoter holding decreased by more than -2% QoQ

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Street Favorite: High Analyst Rating with at least 20% upside

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Companies with high market cap, lower public shareholding

High Piotroski Score - Companies with strong financials

Rising Delivery Percentage Compared to Prev Day

Bullish or Bearish Candlestick Strength - Indices

Expensive Performers (DVM)

Bullish Harami (Bullish Reversal)

Decline in Net Profit with falling Profit Margin (QoQ)